Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 55/100

Failure Rate

18.8%

3 terminated/withdrawn out of 16 trials

Success Rate

76.9%

-9.6% vs industry average

Late-Stage Pipeline

31%

5 trials in Phase 3/4

Results Transparency

20%

2 of 10 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

N/A

3(37.5%)

Phase 4

3(37.5%)

Phase 3

2(25.0%)

8Total

N/A(3)

Phase 4(3)

Phase 3(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (16)

Showing 16 of 16 trials

NCT03045406Phase 3Completed

Apixaban for the Treatment of Venous Thromboembolism in Patients With Cancer

Role: lead

NCT01710488Phase 4Completed

Comparison Between Levofloxacin and Prulifloxacin, in Internal Medicine Patients With Acute Exacerbation of COPD

Role: lead

NCT03651414Terminated

Safety Issues and SurvIval For Medical Outliers

Role: lead

NCT06293768Not ApplicableCompleted

Continuous Wireless Monitoring for Patients in the Internal Medicine UOC. Randomized Controlled Trial (GreenLineH-T)

Role: lead

NCT04267718Not ApplicableCompleted

Efficacy of the Use of Risk Scores in Reducing Important Clinical Outcomes in Hospitalized Medical Ill Patients

Role: lead

NCT05247060Completed

Orthostatic Hypotension in Hypertensive Patient Hospitalized in Internal Medicine

Role: lead

NCT04257422Not ApplicableTerminated

Intentional Rounding in Internal Medicine

Role: lead

NCT05239988Completed

Observational Study in COVID-19 Patients Treated With Remdesivir

Role: lead

NCT05314790Completed

Management of Patients With Diagnosis of Hypothyroidism, as Hospitalized and as Outpatients, in Internal Medicine Units: Observational Study Before & After Educational Programme

Role: lead

NCT03055026Phase 3Completed

Rivaroxaban or Placebo for Extended Antithrombotic Prophylaxis After Laparoscopic Surgery for Colorectal Cancer.

Role: lead

NCT04589533Unknown

MANAGEMENT OF PATIENTS WITH TYPE 2 DIABETES MELLITUS HOSPITALIZED IN INTERNAL MEDICINE UNITS (MINDER Study)

Role: lead

NCT05254522Unknown

Fever of Unknown Orgin Registry in Internal Medicine Unit and Infectious Disease Units

Role: lead

NCT05247931Unknown

Why Does Aspirin Fail in Secondary Cerebrovascular Prevention? A Multicenter Prospective Case - Control Study

Role: lead

NCT03906916Phase 4Terminated

Comparison of Two Diagnostic Tests in Patients With Suspected Invasive Candidiasis in Internal Medicine Wards and Who Are Currently Timely Treated With Micafungin

Role: lead

NCT03798457Completed

Incidence and Prognostic Implication of Acute CV Events in Patients Hospitalized for CAP in Internal Medicine Units.

Role: lead

NCT01718288Phase 4Completed

Optimization of Treatment in Patients With Severe Peripheral Ischemia (Fontaine Stage IIb)

Role: lead

All 16 trials loaded